JUL 30, 2026 · REGULATORY APPROVAL
FDA approval: Fexofenadine Hydrochloride
U.S. Food and Drug Administration
FDA approval of a generic fexofenadine hydrochloride formulation; establishes regulatory authorization but does not report clinical trial efficacy or comparative outcomes.
Reported
Approval date2026-07-30
Application numberANDA220413
Dose strength 160 mg